FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Mar. 29, 2019--
MEDNAX, Inc. (NYSE: MD), today announced its affiliation with Georgia
Neonatology, LLC, a private neonatology practice based in Athens, Ga.
Georgia Neonatology has provided neonatology services to Piedmont
Healthcare’s Piedmont Athens Regional Medical Center location since
2013. The practice specializes in neonatal care for pre-term newborns
and critically ill babies. Under the leadership of Atul Khurana, M.D.,
who serves as medical director, the Piedmont Athens Regional neonatal
intensive care unit (NICU) was upgraded to a state-of-the-art Level III
facility with 20 full-time beds and six overflow beds. Within the
Piedmont Healthcare system, MEDNAX now services five of the eight NICUs
through its network of affiliated physicians.
“As a leader in the neonatal field for 40 years, the MEDNAX national
network offers a wealth of resources that our practice will greatly
benefit from, including their proprietary electronic health record,
which will enhance our clinical systems,” said Dr. Khurana. “MEDNAX will
provide the support needed to further grow the practice while allowing
us to collaborate with colleagues nationwide to provide premier neonatal
care.”
This affiliation adds to the services MEDNAX provides in Georgia through
its network of affiliated physicians across multiple specialties,
including anesthesiology, pain management, maternal-fetal medicine,
neonatology, newborn hearing screen, obstetric hospitalist, pediatric
hospitalist and radiology.
MEDNAX is affiliated with more than 400 NICUs across 36 states plus
Puerto Rico.
This was a cash transaction and it is expected to be immediately
accretive to earnings. No additional terms of the transaction were
disclosed.
ABOUT MEDNAX
MEDNAX, Inc. is a national health solutions partner based in Sunrise,
Fla. comprised of the nation's leading providers of physician services.
Physicians and advanced practitioners practicing as part of MEDNAX are
reshaping the delivery of care within their specialties and
subspecialties, using evidence-based tools, continuous quality
initiatives, clinical research and telemedicine to enhance patient
outcomes and provide high-quality, cost-effective care. The Company was
founded in 1979, and today, through its affiliated professional
corporations, MEDNAX provides services through a network of more than
4,200 physicians in all 50 states and Puerto Rico. In addition to its
national physician network, MEDNAX provides services to healthcare
facilities and physicians in over 40 states through two complementary
businesses, consisting of a revenue cycle management company and a
consulting services company. Additional information is available at www.mednax.com.
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe,” “hope,” “may,” “anticipate,” “should,” “intend,” “plan,”
“will,” “expect,” “estimate,” “project,” “positioned,” “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
MEDNAX undertakes no duty to update or revise any such statements,
whether as a result of new information, future events or otherwise.
Forward-looking statements are not guarantees of future performance and
are subject to risks and uncertainties. Important factors that could
cause actual results, developments, and business decisions to differ
materially from forward-looking statements are described in MEDNAX’s
most recent Annual Report on Form 10-K and its Quarterly Reports on Form
10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s
current reports on Form 8-K,filed with the Securities and Exchange
Commission, and include the effects of economic conditions on MEDNAX’s
business; the effects of the Affordable Care Act and potential changes
thereto or a repeal thereof; MEDNAX’s relationships with
government-sponsored or funded healthcare programs, including Medicare
and Medicaid, and with managed care organizations and commercial health
insurance payors; MEDNAX’s ability to consummate the proposed
disposition of MedData; the effects of share repurchases; and the
effects of MEDNAX’s shared services and operational initiatives.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190329005048/en/
Source: MEDNAX, Inc.
Charles Lynch
Vice President, Strategy and Investor Relations
954-384-0175
ext. 5692
charles_lynch@mednax.com